P1fA, then MDT for Astigmatism

N/A

Waitlist Available

Research Sponsored by Alcon Research

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 8 of each study lens type worn during the corresponding crossover period

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing new soft contact lenses for people with astigmatism to see if they work as well as an existing product. The lenses help improve vision by adjusting how light enters the eye.

Eligible Conditions

Astigmatism
Refractive Errors
Near-sightedness

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 8 of each study lens type worn during the corresponding crossover period

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 8 of each study lens type worn during the corresponding crossover period

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 8 of each study lens type worn during the corresponding crossover period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Least Squares Means Distance Visual Acuity With Study Lenses at Week 1

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: P1fA, then MDTExperimental Treatment2 Interventions

Verofilcon A toric soft contact lenses worn first, followed by stenfilcon A toric soft contact lenses, as randomized. Each study lens type will be worn for 8 (-0/+3) days for at least 10 hours per day. Lenses will be removed nightly and disposed of after a single use.

Group II: MDT, then P1fAExperimental Treatment2 Interventions

Stenfilcon A toric soft contact lenses worn first, followed by verofilcon A toric soft contact lenses, as randomized. Each study lens type will be worn for 8 (-0/+3) days for at least 10 hours per day. Lenses will be removed nightly and disposed of after a single use.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Verofilcon A toric soft contact lenses

2022

N/A

~160

Stenfilcon A toric soft contact lenses

2022

N/A

~160